PEN Q1 2024 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$279M+15.4% YoY

Gross Profit

$181M65.0% margin

Operating Income

$12M4.3% margin

Net Income

$11M3.9% margin

EPS (Diluted)

$0.28

QoQ Revenue Growth

-2.1%

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

$32M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$376M

Stockholders' Equity

$1.2B

Cash & Equivalents

$223M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$279M	$241M	+15.4%
Gross Profit	$181M	$151M	+19.9%
Operating Income	$12M	$8M	+51.1%
Net Income	$11M	$9M	+28.5%

Geographic Segments

UNITED STATES

$210M75%

Other Non-US

$69M25%